| Active principles | Rating | Bibliogr. | Expand |
---|
1 | Tretinoin | 100 | + | |
2 | Arsenicals | 74 | + | |
3 | Oncogene Proteins, Fusion | 62 | + | |
4 | Oxides | 56 | + | |
5 | Receptors, Retinoic Acid | 40 | + | |
6 | Cytarabine | 31 | + | |
7 | Neoplasm Proteins | 26 | + | |
8 | Daunorubicin | 26 | + | |
9 | Idarubicin | 25 | + | |
10 | Benzamides | 20 | + | |
11 | Pyrimidines | 19 | + | |
12 | Nuclear Proteins | 18 | + | |
13 | fms-Like Tyrosine Kinase 3 | 17 | + | |
14 | Piperazines | 16 | + | |
15 | Transcription Factors | 15 | + | |
16 | Fusion Proteins, bcr-abl | 14 | + | |
17 | Sialic Acid Binding Ig-like Lectin 3 | 13 | + | |
18 | Aminoglycosides | 13 | + | |
19 | RNA, Neoplasm | 13 | + | |
20 | Tumor Suppressor Proteins | 12 | + | |
21 | DNA, Neoplasm | 12 | + | |
22 | Retinoids | 12 | + | |
23 | Arsenic | 12 | + | |
24 | Kruppel-Like Transcription Factors | 10 | + | |
25 | Myeloid-Lymphoid Leukemia Protein | 9 | + | |
26 | Harringtonines | 9 | + | |
27 | 6-Mercaptopurine | 9 | + | |
28 | Leukemia Inhibitory Factor | 9 | + | |
29 | Protein-Tyrosine Kinases | 8 | + | |
30 | Asparaginase | 7 | + | |
31 | RNA, Messenger | 7 | + | |
32 | Anthracyclines | 7 | + | |
33 | Bryostatins | 7 | + | |
34 | HLA-B13 Antigen | 7 | + | |
35 | Core Binding Factor Alpha 2 Subunit | 7 | + | |
36 | Nuclear Receptor Co-Repressor 1 | 6 | + | |
37 | Nuclear Receptor Co-Repressor 2 | 6 | + | |
38 | Proto-Oncogene Proteins | 6 | + | |
39 | DNA-Binding Proteins | 6 | + | |
40 | Thiazoles | 6 | + | |
41 | Cladribine | 6 | + | |
42 | Caspases | 6 | + | |
43 | Vidarabine | 6 | + | |
44 | Antigens, CD56 | 6 | + | |
45 | Arabinonucleosides | 5 | + | |
46 | Thioguanine | 5 | + | |
47 | Proto-Oncogene Proteins c-bcl-2 | 5 | + | |
48 | Retinoid X Receptors | 5 | + | |
49 | CCAAT-Enhancer-Binding Protein-alpha | 5 | + | |
50 | Bisbenzimidazole | 5 | + | |
51 | Azacitidine | 5 | + | |
52 | Arsenites | 5 | + | |
53 | Methotrexate | 5 | + | |
54 | Sulfides | 5 | + | |
55 | Annexin A2 | 5 | + | |
56 | Vincristine | 5 | + | |
57 | Arsenates | 5 | + | |
58 | Antibodies, Monoclonal | 5 | + | |
59 | Phosphoglycerate Kinase | 5 | + | |
60 | Deoxycytidine Monophosphate | 5 | + | |
61 | Propidium | 4 | + | |
62 | Mitoxantrone | 4 | + | |
63 | Recombinant Fusion Proteins | 4 | + | |
64 | Etoposide | 4 | + | |
65 | Hydroxyurea | 4 | + | |
66 | Granulocyte Colony-Stimulating Factor | 4 | + | |
67 | Carrier Proteins | 4 | + | |
68 | Thrombomodulin | 4 | + | |
69 | Formazans | 4 | + | |
70 | Pyronine | 4 | + | |
71 | Amsacrine | 4 | + | |
72 | Receptors, Colony-Stimulating Factor | 4 | + | |
73 | Mediator Complex | 4 | + | |
74 | WT1 Proteins | 4 | + | |
75 | Pyrogallol | 4 | + | |
76 | Mutant Chimeric Proteins | 4 | + | |
77 | Myeloid Cell Leukemia Sequence 1 Protein | 4 | + | |
78 | P-Glycoprotein | 4 | + | |
79 | Bone Morphogenetic Protein Receptors | 4 | + | |
80 | Reactive Oxygen Species | 3 | + | |
81 | Repressor Proteins | 3 | + | |
82 | Small Ubiquitin-Related Modifier Proteins | 3 | + | |
83 | Bone Morphogenetic Protein Receptors, Type I | 3 | + | |
84 | Proto-Oncogene Proteins c-abl | 3 | + | |
85 | Proto-Oncogene Proteins c-bcr | 3 | + | |
86 | Caspase 3 | 3 | + | |
87 | Busulfan | 3 | + | |
88 | DNA Primers | 3 | + | |
89 | Tetrahydronaphthalenes | 3 | + | |
90 | Immunotoxins | 3 | + | |
91 | Cyclophosphamide | 3 | + | |
92 | Doxorubicin | 3 | + | |
93 | Methylthioinosine | 3 | + | |
94 | Trans-Activators | 3 | + | |
95 | Adenine Nucleotides | 3 | + | |
96 | Chlorambucil | 3 | + | |
97 | Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 3 | + | |
98 | Telomerase | 3 | + | |
99 | alpha-2-Antiplasmin | 3 | + | |
100 | Arabinofuranosylcytosine Triphosphate | 3 | + | |
101 | Core Binding Factors | 3 | + | |
102 | Interferon-alpha | 3 | + | |
103 | Organic Cation Transporter 1 | 3 | + | |
104 | Fibrinopeptide A | 3 | + | |
105 | DNA Nucleotidylexotransferase | 3 | + | |
106 | Naphthacenes | 3 | + | |
107 | Hydroxamic Acids | 3 | + | |
108 | CCAAT-Enhancer-Binding Proteins | 3 | + | |
109 | Interferon Type I | 2 | + | |
110 | Aclarubicin | 2 | + | |
111 | Benzoates | 2 | + | |
112 | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | + | |
113 | Dioxolanes | 2 | + | |
114 | Deoxycytidine Kinase | 2 | + | |
115 | Deoxyadenosines | 2 | + | |
116 | RNA Isoforms | 2 | + | |
117 | Histones | 2 | + | |
118 | Prednisone | 2 | + | |
119 | Arabinonucleotides | 2 | + | |
120 | bcl-2-Associated X Protein | 2 | + | |
121 | Antibodies, Neoplasm | 2 | + | |
122 | Thromboplastin | 2 | + | |
123 | Antigens, CD45 | 2 | + | |
124 | STAT5 Transcription Factor | 2 | + | |
125 | Recombinant Proteins | 2 | + | |
126 | Interleukin-3 Receptor alpha Subunit | 2 | + | |
127 | DNA Nucleotidyltransferases | 2 | + | |
128 | Coformycin | 2 | + | |
129 | Antigens, CD95 | 2 | + | |
130 | Histone Deacetylases | 2 | + | |
131 | Fibrin Fibrinogen Degradation Products | 2 | + | |
132 | Immunoglobulin Heavy Chains | 2 | + | |
133 | Phosphotransferases | 2 | + | |
134 | Asparagine | 2 | + | |
135 | Antibodies, Monoclonal, Humanized | 2 | + | |
136 | 2-Chloroadenosine | 2 | + | |
137 | Protein Isoforms | 2 | + | |
138 | Oncogene Proteins | 2 | + | |
139 | Ribosome Inactivating Proteins, Type 1 | 2 | + | |
140 | DNA (Cytosine-5-)-Methyltransferase | 2 | + | |
141 | Aniline Compounds | 2 | + | |
142 | Farnesyltranstransferase | 2 | + | |
143 | Cyclin-Dependent Kinase Inhibitor p15 | 2 | + | |
144 | Cytidine Deaminase | 2 | + | |
145 | Octamer Transcription Factor-1 | 2 | + | |
146 | GATA1 Transcription Factor | 2 | + | |
147 | Receptors, Granulocyte Colony-Stimulating Factor | 2 | + | |
148 | Receptors, Interleukin-3 | 2 | + | |
149 | src-Family Kinases | 2 | + | |
150 | Purine Nucleosides | 2 | + | |
151 | Staurosporine | 2 | + | |
152 | Receptors, Antigen, B-Cell | 2 | + | |
153 | N-Glycosyl Hydrolases | 1 | + | |
154 | Receptor Protein-Tyrosine Kinases | 1 | + | |
155 | Diphtheria Toxin | 1 | + | |
156 | Natural Cytotoxicity Triggering Receptor 2 | 1 | + | |
157 | Nuclear Pore Complex Proteins | 1 | + | |
158 | Janus Kinase 2 | 1 | + | |
159 | 5'-Nucleotidase | 1 | + | |
160 | Cytidine Monophosphate | 1 | + | |
161 | ZAP-70 Protein-Tyrosine Kinase | 1 | + | |
162 | Antigens, CD38 | 1 | + | |
163 | Receptor, Muscarinic M2 | 1 | + | |
164 | Receptor, Muscarinic M1 | 1 | + | |
165 | Nitrogen Mustard Compounds | 1 | + | |
166 | Interleukin-2 | 1 | + | |
167 | Adaptor Proteins, Signal Transducing | 1 | + | |
168 | Thrombin | 1 | + | |
169 | Protein-Serine-Threonine Kinases | 1 | + | |
170 | Receptor, Notch1 | 1 | + | |
171 | Tumor Suppressor Protein p53 | 1 | + | |
172 | Homeodomain Proteins | 1 | + | |
173 | Cell Adhesion Molecules | 1 | + | |
174 | RNA, Small Interfering | 1 | + | |
175 | Protein Kinases | 1 | + | |
176 | Aminoacridines | 1 | + | |
177 | DNA Polymerase II | 1 | + | |
178 | Glycophorin | 1 | + | |
179 | Ricin | 1 | + | |
180 | Membrane Glycoproteins | 1 | + | |
181 | Apoptosis Regulatory Proteins | 1 | + | |
182 | Complement System Proteins | 1 | + | |
183 | Ribonucleosides | 1 | + | |
184 | Sialic Acid Binding Ig-like Lectin 2 | 1 | + | |
185 | Receptors, KIR | 1 | + | |
186 | Proto-Oncogene Proteins c-myc | 1 | + | |
187 | Thymidine | 1 | + | |
188 | Antibodies, Monoclonal, Murine-Derived | 1 | + | |
189 | Trimetrexate | 1 | + | |
190 | Interleukin-3 | 1 | + | |
191 | Multidrug Resistance-Associated Proteins | 1 | + | |
192 | Phenylurea Compounds | 1 | + | |
193 | Thionucleotides | 1 | + | |
194 | ATP-Binding Cassette Transporters | 1 | + | |
195 | Ribonucleotide Reductases | 1 | + | |
196 | mRNA Cleavage and Polyadenylation Factors | 1 | + | |
197 | Gene Products, tax | 1 | + | |
198 | Buthionine Sulfoximine | 1 | + | |
199 | Proto-Oncogene Proteins c-kit | 1 | + | |
200 | Cell Cycle Proteins | 1 | + | |
201 | Prednisolone | 1 | + | |
202 | DNA Probes | 1 | + | |
203 | Plant Extracts | 1 | + | |
204 | Aspartate-Ammonia Ligase | 1 | + | |
205 | Nocodazole | 1 | + | |
206 | Reticulin | 1 | + | |
207 | MicroRNAs | 1 | + | |
208 | Thioinosine | 1 | + | |
209 | Annexin A5 | 1 | + | |
210 | Pyridines | 1 | + | |
211 | Protein Phosphatase 2 | 1 | + | |
212 | Receptors, Immunologic | 1 | + | |
213 | Isotretinoin | 1 | + | |
214 | Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | + | |
215 | Interleukin Receptor Common gamma Subunit | 1 | + | |
216 | Antigens, CD13 | 1 | + | |
217 | Aurora Kinases | 1 | + | |
218 | Guanosine Triphosphate | 1 | + | |
219 | Rhodamine 123 | 1 | + | |
220 | Proto-Oncogene Proteins c-akt | 1 | + | |
221 | Caspase 8 | 1 | + | |
222 | Phosphatidylinositol 3-Kinases | 1 | + | |
223 | Casein Kinase Ialpha | 1 | + | |
224 | Vault Ribonucleoprotein Particles | 1 | + | |
225 | Nitrosourea Compounds | 1 | + | |
226 | Boronic Acids | 1 | + | |
227 | Proto-Oncogene Proteins c-pim-1 | 1 | + | |
228 | Cyclin D3 | 1 | + | |
229 | DNA | 1 | + | |
230 | Pyrazines | 1 | + | |
231 | Lymphokines | 1 | + | |
232 | Phospholipid Ethers | 1 | + | |
233 | Immunoconjugates | 1 | + | |
234 | Receptor, Muscarinic M4 | 1 | + | |
235 | Nucleosides | 1 | + | |
236 | Benzoquinones | 1 | + | |
237 | Antigens, CD44 | 1 | + | |
238 | Intracellular Signaling Peptides and Proteins | 1 | + | |
239 | Teniposide | 1 | + | |
240 | Mitoguazone | 1 | + | |
241 | bcl-X Protein | 1 | + | |
242 | Peptide Synthases | 1 | + | |
243 | Cytosine | 1 | + | |
244 | Immunoglobulin M | 1 | + | |
245 | Vindesine | 1 | + | |
246 | Plant Proteins | 1 | + | |
247 | DNA Topoisomerases, Type II | 1 | + | |
248 | Isocitrate Dehydrogenase | 1 | + | |
249 | Ataxia Telangiectasia Mutated Proteins | 1 | + | |
250 | Polyglutamic Acid | 1 | + | |
251 | Interferons | 1 | + | |
252 | Receptors, Interleukin-2 | 1 | + | |
253 | Pipobroman | 1 | + | |
254 | Caspase 9 | 1 | + | |
255 | Colony-Stimulating Factors | 1 | + | |
256 | Thionucleosides | 1 | + | |
257 | Membrane Proteins | 1 | + | |
258 | Vidarabine Phosphate | 1 | + | |
259 | Dexamethasone | 1 | + | |
260 | Deoxyribonucleotides | 1 | + | |
261 | Niacinamide | 1 | + | |
262 | Cytokine Receptor Common beta Subunit | 1 | + | |
263 | Benzenesulfonates | 1 | + | |
264 | Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | + | |
265 | DNA Modification Methylases | 1 | + | |
266 | Mechlorethamine | 1 | + | |
267 | Anthraquinones | 1 | + | |
268 | HSP90 Heat-Shock Proteins | 1 | + | |
269 | Uridine | 1 | + | |
270 | Indoles | 1 | + | |
271 | Pyrimidine Nucleotides | 1 | + | |
272 | Cyclin D2 | 1 | + | |
273 | RNA-Binding Protein FUS | 1 | + | |
274 | bcl-2 Homologous Antagonist-Killer Protein | 1 | + | |
275 | DNA, Complementary | 1 | + | |
276 | Immunoglobulin Variable Region | 1 | + | |
277 | Tetraspanins | 1 | + | |
278 | Hypoxanthine Phosphoribosyltransferase | 1 | + | |
279 | Receptors, Glucocorticoid | 1 | + | |
280 | Core Binding Factor alpha Subunits | 1 | + | |
281 | Equilibrative Nucleoside Transporter 1 | 1 | + | |
282 | Histone-Lysine N-Methyltransferase | 1 | + | |
283 | Thalidomide | 1 | + | |
284 | Oligonucleotides, Antisense | 1 | + | |
285 | Proto-Oncogene Proteins c-raf | 1 | + | |
286 | Podophyllotoxin | 1 | + | |
287 | Myeloblastin | 1 | + | |
288 | Proto-Oncogene Proteins c-jun | 1 | + | |
289 | Ikaros Transcription Factor | 1 | + | |
290 | Receptors, CXCR4 | 1 | + | |
291 | Core Binding Factor beta Subunit | 1 | + | |
292 | Aminopterin | 1 | + | |
293 | TOR Serine-Threonine Kinases | 1 | + | |
294 | Dactinomycin | 1 | + | |
295 | Antigens, CD79 | 1 | + | |
296 | Inhibitor of Apoptosis Proteins | 1 | + | |
297 | X-Linked Inhibitor of Apoptosis Protein | 1 | + | |
298 | Lactams, Macrocyclic | 1 | + | |
299 | bcl-Associated Death Protein | 1 | + | |
300 | Cytidine | 1 | + | |
301 | Antigens, CD47 | 1 | + | |
302 | Deoxyuridine | 1 | + | |
303 | Proto-Oncogene Proteins c-myb | 1 | + | |
304 | Flavonoids | 1 | + | |